Fierce Pharma
JULY 23, 2024
After making major manufacturing outlays in places like China and the United States earlier this year, Novo Nordisk is returning to its Danish roots. | Earlier this month, Novo Nordisk purchased a 200-acre site in Odense, Denmark’s third largest city, the company has confirmed. Novo is now set to kick off preparatory excavation work for a potential new production plant.
MedCity News
JULY 23, 2024
The National Community Pharmacists Association and providers argued that Change Healthcare didn’t take the needed precautions against the cyberattack that happened earlier this year. The post NCPA, Providers File Lawsuit Against UHG Over Change Healthcare Cyberattack appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JULY 23, 2024
Interim results from a phase 3 trial of AstraZeneca’s Imfinzi as a treatment before and after surgery in resectable non-small cell lung cancer (NSCLC) were head scratching as they failed to answer | An FDA advisory committee will discuss AstraZeneca’s application for Imfinzi in early-stage non-small cell lung cancer. The agency is asking external experts to weigh in on whether a new trial is needed to determine the contributions of the therapy on either end of surgery.
MedCity News
JULY 23, 2024
By prioritizing user-centric design, responsible data practices, and evidence-based solutions neurotech companies can not only drive user adoption but also foster long-term brand loyalty. The post Earning Trust in Neurotech appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Referral MD
JULY 23, 2024
ReferralMD, a leader in healthcare technology solutions, is excited to announce that Baptist Memorial Health Care, one of the nation’s largest not-for-profit health care systems and the largest Medicaid provider in the region, has significantly improved their referral management process with ReferralMD. The centralized Referral Center at Baptist Memorial sought a comprehensive referral management platform to replace their previous system.
pharmaphorum
JULY 23, 2024
Agilent has boosted its contract development and manufacturing organisation (CDMO) capacity with a $925 million deal to buy Biovectra, a Canadian provider of fill-and-finish services and active pharmaceutical ingredients (APIs).It's a statement of intent from Agilent, whose primary business is lab instrumentation and equipment, suggesting that it intends to grow the outsourcing side of its business, which is currently focused on the production of oligonucleotide and peptide medicines.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
JULY 23, 2024
Former Welsh rugby union captain Alum Wyn Jones is the face of a new awareness campaign launching in the UK today to draw attention to atrial fibrillation (AF), an irregular and potentially life-threatening heart rhythm abnormality.
Pharmaceutical Technology
JULY 23, 2024
Johnson & Johnson is seeking approval for SPRAVATO for treatment-resistant depression with the submission of an sNDA to the US FDA.
pharmaphorum
JULY 23, 2024
GSK has challenged Gilead's HIV behemoth Biktarvy, presenting data that its competing therapy Dovato is equally effective and associated with less weight gain.
MedCity News
JULY 23, 2024
Abiologics develops biologic drugs from building blocks not found in nature, which it says confers these proteins with properties that make for better medicines. Founded by Flagship Pioneering, the startup is focusing on developing novel biologic treatments for cancer and immunology. The post Flagship Pioneering Launches Startup Abiologics to Advance New Class of Biologic Drugs appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
JULY 23, 2024
Ionis plans phase 3 trial of its antisense therapy for Angelman syndrome, shortly after Biogen decided against exercising an option to license the drug
MedCity News
JULY 23, 2024
As population health management becomes a vital element for long-term success, it’s time to take a closer look at what is holding providers and health plans from gaining the value they seek. The post Gaining the Right Value from Population Health Management: 3 Secrets to Success appeared first on MedCity News.
Healthcare Success
JULY 23, 2024
Entrepreneurial Insights from a Market Disruptor Market disrupters are drastically changing the healthcare industry, creating more accessible solutions and lucrative business models by addressing unmet needs with innovative solutions and scalable business models. Psych360 was one of the early disruptors to transform access to mental health care in long-term care facilities.
pharmaphorum
JULY 23, 2024
In today’s podcast, web editor Nicole Raleigh speaks with Carolyn Ward, director of clinical strategy at Particle Health Inc, a data transformation platform for healthcare, enabling organisations across the care continuum to turn medical records into actionable insights.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
PharmaTimes
JULY 23, 2024
The life-threatening medical condition affects 100,000 people in the UK every year
pharmaphorum
JULY 23, 2024
Johnson & Johnson has filed for FDA approval of its antidepressant nasal spray Spravato, hoping to make it the first standalone treatment for adults with treatment-resistant depression (TRD).Spravato (esketamine) is already approved in the US as an add-on to oral antidepressant therapy for TRD, as well as for depressive symptoms in adults with major depressive disorder (MDD) and suicidal thoughts or behaviours.
Pharmaceutical Commerce
JULY 23, 2024
The deal exponentially grows the CDMO’s biopharma capabilities.
PharmaTech
JULY 23, 2024
The addition of BIOVECTRA’s biologics capabilities to accelerate drug development and manufacturing will allow Agilent to expand its end-to-end offerings for biopharma services.
Pharmaceutical Commerce
JULY 23, 2024
The latest news for pharma industry insiders.
PharmaTimes
JULY 23, 2024
The neurological disease is estimated to affect more than ten million people globally
Nixon Gwilt Law
JULY 23, 2024
In the recently released 2025 Medicare Physician Fee Schedule Proposed Rule (the “Proposed Rule”), the Centers for Medicare & Medicaid Services (CMS) created a new reimbursement pathway for “Digital Mental Health Treatment” (DMHT) devices and services. As we mentioned in our overview of the Proposed Rule , this new pathway is a major step in the right direction for reimbursement of digital therapeutics (DTx) interventions more broadly.
PharmaTech
JULY 23, 2024
Lipid-based formulations (LBFs) and softgels can offer numerous advantages in terms of clinical and commercial potential. Integrating formulation and manufacturing to enhance drug solubility and market speed can help unlock these benefits.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmExec
JULY 23, 2024
The trial is expected to include 40 patients across the United States who haven’t responded adequately to standard hypovolemic septic shock treatments and are on vasopressors.
PharmaTech
JULY 23, 2024
The increasing number of breakthroughs in small molecule drug development are exciting, but corresponding workflows are complex and require much more tailored approaches to ensure successful upstream and downstream processing, drug approvals and commercialization.
Prognos Health
JULY 23, 2024
The landscape of Non-Small Cell Lung Cancer (NSCLC) treatment is constantly evolving, with personalized medicine playing an increasingly vital role. In this pursuit, advanced diagnostic tools like FISH (Fluorescence In Situ Hybridization) panels have become instrumental. Recently, we’ve had a chance to assess exciting new data from a major laboratory's FISH panel, offering valuable insights for pharmaceutical companies working to target clinicians and patients.
PharmaTech
JULY 23, 2024
Speed to market is a critical aspect of developing new pharmaceutical products, and scale-up-or scale-down-can play a key part in that process. Significant interest has been focused on the science of scale for spray drying, since this process is the leading technology for formulating drugs with slow dissolution rates or poor solubility, which results in low bioavailability.
Nixon Gwilt Law
JULY 23, 2024
In the recently released 2025 Medicare Physician Fee Schedule Proposed Rule (the “Proposed Rule”), the Centers for Medicare & Medicaid Services (CMS) created a new reimbursement pathway for “Digital Mental Health Treatment” (DMHT) devices and services. As we mentioned in our overview of the Proposed Rule , this new pathway is a major step in the right direction for reimbursement of digital therapeutics (DTx) interventions more broadly.
PharmaTech
JULY 23, 2024
While the document does not address treatment or prevention of the long-term complications of ulcerative colitis or Crohn’s disease in children, it aims to help sponsors developing drugs for pediatric patients currently affected.
European Pharmaceutical Review
JULY 23, 2024
A collaborative study involving several pharmaceutical companies has proposed reconsideration of employing naturally occurring endotoxins (NOEs) in endotoxin recovery studies. Following up on their initial research, in this part 2 of their study, the research team evaluated naturally occurring endotoxins prepared in high and low nutrient conditions in two common monoclonal antibody (mAb) buffer formulations.
PharmExec
JULY 23, 2024
In this part of his Pharmaceutical Executive video interview, Joshua M. Cohen, MD, MPH, FAHS, Chief Medical Officer, Braeburn discusses how the findings from this study contribute to addressing treatment gaps and improving patient outcomes for those struggling with fentanyl dependence, ensuring broader patient access to BRIXADI®, and more.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
267 
Let's personalize your content